Ladulaas AB
- Address
- Skaraborgsvagen 35e, Boras Caroli, 506 30 Borås, Sweden
Cardiovascular Diseases
At Ladulaas AB, investigators are evaluating novel therapies aimed at reducing risk in patients with atherosclerotic cardiovascular disease and elevated lipoprotein(a). The studies seek to demonstrate safety and effectiveness in preventing heart attacks and related events.
- Evaluation of lipoprotein(a) lowering agents
- Assessment of coronary heart disease outcomes
- Comparison of new medication versus placebo in ASCVD patients
The department has launched two clinical studies with three investigators, contributing to Sweden’s growing portfolio of cardiovascular research.
Nutritional and Metabolic Diseases
Research at the clinic includes a trial testing survodutide as an adjunct to calorie restriction and increased activity for adults with obesity, aiming to prove superiority over placebo for weight reduction.
- Investigation of weight‑loss efficacy without diabetes
- Integration of lifestyle modification with pharmacotherapy
- Safety and tolerability assessment in high‑BMI participants
These efforts align with the site’s focus on metabolic health, expanding therapeutic options for patients struggling with obesity.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 188 other sites in Sweden
Therapeutic Area Benchmark — Sweden
Select a therapeutic area to compare against other sites in Sweden.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Sweden
Market Share
Country: Sweden
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Ladulaas AB
lock Showing 1 of 7 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, randomised, double-blind, parallel-group, 76-week, efficacy and safety study of BI 456906 administered subcutaneously compared with placebo in participants with overweight or obesity and type 2 diabetes mellitus | Boehringer Ingelheim Espana S.A., Boehringer Ingelheim International GmbH, Boehringer Ingelheim RCV GmbH & Co. KG | Phase III | Not Recruiting | Jan 2024 | Mar 2026 |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| BI 456906 | 2 | Unknown | 2024-01-18 | 2024-01-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.